XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Alle auswählen Alle zurücksetzen

Speichern Schließen

(%)

US78464A8707

XBI ISIN

Exchange Traded Funds (ETF)

Fondstyp

SPDR State Street Global Advisors

Anbieter

135,34 USD

NAV pro Aktie | 16/06/2026

31/01/2006

Startdatum

4 Wiederholungen pro Jahr

Ausschüttung von Dividenden

CEOILS

CFI

XBI

Ticker

Formed

Status

Equity

Investitionsobjekt

Biotech

Sektor

USA

Geographie

S&P Biotechnology Select Industry Index

Benchmark

0.35 %

Gesamtkostenquote

8.397,64 Mio. USD

Gesamtes Fondsvermögen | 16/06/2026

8.397,64 Mio. USD

Aktien-Anlageklasse Volumen | 16/06/2026

Nein

UCITS

1 / 3 (11/09/2015)

Split

Rendite auf 16/06/2026, NYSE Arca

YTD

5,06 %
1M

-7,93 %
3M

1,65 %
6M

11,2 %
1J

62,15 %
3J

51,47 %
5J

0,91 %
10J

143,19 %

Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum

Zum Vergleichen hinzufügen

Kurse (XBI)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener
Watchlist
Excel-Add-In

Zugang erhalten

Kurs-Dynamik

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Struktur XBI auf 15/06/2026

Struktur in Excel herunterladen

Wertpapier	Wertpapier
TRAVERE THERAPEUTICS INC	2,06%
TG THERAPEUTICS INC	2,03%
TWIST BIOSCIENCE CORP	1,95%
REVOLUTION MEDICINES INC	1,82%
ALKERMES PLC	1,81%
ARROWHEAD PHARMACEUTICALS IN	1,5%
KRYSTAL BIOTECH INC	1,44%
EXELIXIS INC	1,44%
NUVALENT INC A	1,4%
NEUROCRINE BIOSCIENCES INC	1,39%
BEAM THERAPEUTICS INC	1,35%
PTC THERAPEUTICS INC	1,32%
PROTAGONIST THERAPEUTICS INC	1,32%
MADRIGAL PHARMACEUTICALS INC	1,31%
APOGEE THERAPEUTICS INC	1,31%
VERACYTE INC	1,29%
CYTOKINETICS INC	1,27%
NATERA INC	1,25%
MIRUM PHARMACEUTICALS INC	1,25%
INCYTE CORP	1,22%
HALOZYME THERAPEUTICS INC	1,21%
SCHOLAR ROCK HOLDING CORP	1,2%
SPYRE THERAPEUTICS INC	1,19%
CRISPR THERAPEUTICS AG	1,19%
KYMERA THERAPEUTICS INC	1,19%
BIOGEN INC	1,18%
ARCUTIS BIOTHERAPEUTICS INC	1,18%
ROIVANT SCIENCES LTD	1,15%
IMMUNOVANT INC	1,15%
UNITED THERAPEUTICS CORP	1,14%
RHYTHM PHARMACEUTICALS INC	1,13%
IONIS PHARMACEUTICALS INC	1,12%
ABBVIE INC	1,1%
BRIDGEBIO PHARMA INC	1,08%
MODERNA INC	1,05%
ULTRAGENYX PHARMACEUTICAL IN	1,05%
AMGEN INC	1,05%
BIOMARIN PHARMACEUTICAL INC	1,04%
COGENT BIOSCIENCES INC	1,04%
VERTEX PHARMACEUTICALS INC	1,04%
ALNYLAM PHARMACEUTICALS INC	1,02%
CG ONCOLOGY INC	1,02%
PRAXIS PRECISION MEDICINES I	1,01%
IMMUNITYBIO INC	0,98%
VAXCYTE INC	0,98%
ACADIA PHARMACEUTICALS INC	0,97%
GILEAD SCIENCES INC	0,96%
CATALYST PHARMACEUTICALS INC	0,95%
DISC MEDICINE INC	0,95%
VIKING THERAPEUTICS INC	0,94%
SUMMIT THERAPEUTICS INC	0,92%
ERASCA INC	0,91%
REGENERON PHARMACEUTICALS	0,9%
VERA THERAPEUTICS INC	0,87%
TANGO THERAPEUTICS INC	0,87%
CELCUITY INC	0,86%
DYNE THERAPEUTICS INC	0,86%
DENALI THERAPEUTICS INC	0,84%
GRAIL INC	0,83%
AGIOS PHARMACEUTICALS INC	0,82%
BIOCRYST PHARMACEUTICALS INC	0,81%
INSMED INC	0,79%
INTELLIA THERAPEUTICS INC	0,75%
RECURSION PHARMACEUTICALS A	0,74%
IMMUNOME INC	0,71%
ORUKA THERAPEUTICS INC	0,7%
ARCUS BIOSCIENCES INC	0,7%
IDEAYA BIOSCIENCES INC	0,66%
DIANTHUS THERAPEUTICS INC	0,65%
SAREPTA THERAPEUTICS INC	0,64%
NURIX THERAPEUTICS INC	0,64%
UNIQURE NV	0,63%
BIOHAVEN LTD	0,62%
KODIAK SCIENCES INC	0,61%
ARDELYX INC	0,58%
MANNKIND CORP	0,58%
VIRIDIAN THERAPEUTICS INC	0,58%
SYNDAX PHARMACEUTICALS INC	0,58%
NOVAVAX INC	0,57%
VERICEL CORP	0,57%
MINERALYS THERAPEUTICS INC	0,57%
RELAY THERAPEUTICS INC	0,56%
ADMA BIOLOGICS INC	0,56%
CELLDEX THERAPEUTICS INC	0,52%
SELLAS LIFE SCIENCES GROUP I	0,48%
CAREDX INC	0,47%
MONTE ROSA THERAPEUTICS INC	0,47%
STOKE THERAPEUTICS INC	0,45%
TAYSHA GENE THERAPIES INC	0,45%
ABSCI CORP	0,44%
IOVANCE BIOTHERAPEUTICS INC	0,44%
PALVELLA THERAPEUTICS INC	0,43%
CAPRICOR THERAPEUTICS INC	0,42%
ANAPTYSBIO INC	0,41%
PRECIGEN INC	0,38%
INHIBRX BIOSCIENCES INC	0,37%
CORVUS PHARMACEUTICALS INC	0,34%
OLEMA PHARMACEUTICALS INC	0,33%
KURA ONCOLOGY INC	0,32%
RIGEL PHARMACEUTICALS INC	0,32%

Alle anzeigen Verstecken

Andere - %